Creating a platform to study HIV and joint diseases in Uganda
Building a Collaborative Research and Training Platform for HIV and Rheumatic and Musculoskeletal Diseases in Uganda
This study is creating a helpful platform for people in Uganda who have both HIV and joint or muscle diseases, so we can better understand how these conditions affect each other and improve care for everyone living with them.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10998759 on NIH RePORTER |
What this research studies
This research aims to establish a collaborative platform that focuses on patients living with HIV and rheumatic and musculoskeletal diseases (RMDs) in Uganda. By creating a registry of these patients, the project will facilitate better understanding and management of the interactions between HIV and RMDs, which are increasingly prevalent in the region. The approach includes collecting epidemiological and clinical data to improve patient care and outcomes. This initiative addresses the growing challenge of non-communicable diseases among individuals with HIV, aiming to enhance healthcare strategies in resource-limited settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who also suffer from rheumatic and musculoskeletal diseases.
Not a fit: Patients without HIV or those who do not have rheumatic and musculoskeletal diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management and treatment strategies for patients with HIV and RMDs, ultimately enhancing their quality of life.
How similar studies have performed: While the specific approach of this research is novel, there is growing evidence that addressing co-morbidities in HIV patients can lead to significant improvements in health outcomes.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Hsieh, Evelyn — Yale University
- Study coordinator: Hsieh, Evelyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.